[go: up one dir, main page]

FI852273A0 - Foerfarande foer framstaellning av en mot mekaniska belastningar stabiliserad vattenhaltig insulinberedning och dess anvaendning. - Google Patents

Foerfarande foer framstaellning av en mot mekaniska belastningar stabiliserad vattenhaltig insulinberedning och dess anvaendning.

Info

Publication number
FI852273A0
FI852273A0 FI852273A FI852273A FI852273A0 FI 852273 A0 FI852273 A0 FI 852273A0 FI 852273 A FI852273 A FI 852273A FI 852273 A FI852273 A FI 852273A FI 852273 A0 FI852273 A0 FI 852273A0
Authority
FI
Finland
Prior art keywords
plunger pipe
plate
stabiliserad
insulinberedning
belastningar
Prior art date
Application number
FI852273A
Other languages
English (en)
Other versions
FI80596B (fi
FI80596C (fi
FI852273L (fi
Inventor
Ulrich Grau
Gerhard Ross
Dietrich Hiller
Horst Paul Neubauer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19843443877 external-priority patent/DE3443877A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI852273A0 publication Critical patent/FI852273A0/fi
Publication of FI852273L publication Critical patent/FI852273L/fi
Publication of FI80596B publication Critical patent/FI80596B/fi
Application granted granted Critical
Publication of FI80596C publication Critical patent/FI80596C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Luminescent Compositions (AREA)
  • Steroid Compounds (AREA)
  • Prostheses (AREA)
  • External Artificial Organs (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
FI852273A 1984-06-09 1985-06-06 Foerfarande foer framstaellning av en mot mekaniska belastningar stabiliserad vattenhaltig insulinberedning och anvaendning av ett fysiologiskt godtagbart fortjockningsmedel och en aktiv substans foer stabilisering av vattenhaltiga insulinpreparat. FI80596C (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE3421615 1984-06-09
DE3421613 1984-06-09
DE3421615 1984-06-09
DE3421613 1984-06-09
DE19843443877 DE3443877A1 (de) 1984-06-09 1984-12-01 Insulinzubereitungen, verfahren zu deren herstellung und deren verwendung
DE3443877 1984-12-01

Publications (4)

Publication Number Publication Date
FI852273A0 true FI852273A0 (fi) 1985-06-06
FI852273L FI852273L (fi) 1985-12-10
FI80596B FI80596B (fi) 1990-03-30
FI80596C FI80596C (fi) 1990-07-10

Family

ID=27192050

Family Applications (1)

Application Number Title Priority Date Filing Date
FI852273A FI80596C (fi) 1984-06-09 1985-06-06 Foerfarande foer framstaellning av en mot mekaniska belastningar stabiliserad vattenhaltig insulinberedning och anvaendning av ett fysiologiskt godtagbart fortjockningsmedel och en aktiv substans foer stabilisering av vattenhaltiga insulinpreparat.

Country Status (16)

Country Link
EP (1) EP0166971B1 (fi)
AT (1) ATE50502T1 (fi)
AU (1) AU575951B2 (fi)
CA (1) CA1258427A (fi)
DE (1) DE3576120D1 (fi)
DK (1) DK162255C (fi)
ES (1) ES8605679A1 (fi)
FI (1) FI80596C (fi)
GR (1) GR851393B (fi)
HU (1) HU200102B (fi)
IE (1) IE57998B1 (fi)
IL (1) IL75448A (fi)
NO (1) NO164277C (fi)
NZ (1) NZ212338A (fi)
PH (1) PH24118A (fi)
PT (1) PT80620B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO179479C (no) * 1988-03-11 1996-10-16 Teikoku Seiyaku Kk Fremgangsmåte for fremstilling av et intravaginalt farmasöytisk preparat
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
KR101820024B1 (ko) 2008-10-17 2018-01-18 사노피-아벤티스 도이칠란트 게엠베하 인슐린과 ｇｌｐ－1 효능제의 병용물
LT2498801T (lt) 2009-11-13 2018-05-10 Sanofi-Aventis Deutschland Gmbh Farmacinė kompozicija, apimanti despro36eksendin-4(1-39)-lys6-nh2 ir metioniną
PL3417871T3 (pl) 2009-11-13 2021-06-14 Sanofi-Aventis Deutschland Gmbh Kompozycja farmaceutyczna zawierająca agonistę GLP-1, insulinę i metioninę
MX339614B (es) 2010-08-30 2016-06-02 Sanofi - Aventis Deutschland GmbH Uso de ave0010 para la fabricacion de un medicamento para el tratamiento de la diabetes mellitus tipo 2.
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
CN110354255B (zh) 2013-04-03 2024-05-14 赛诺菲 通过长效胰岛素制剂治疗糖尿病
CA2970200A1 (en) 2014-12-12 2016-06-16 Sanofi-Aventis Deutschland Gmbh Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2474729A (en) * 1945-01-03 1949-06-28 Rhone Poulenc Sa Insulin preparations
US2574889A (en) * 1947-10-06 1951-11-13 Leo Ab Methylated gelatin-insulin preparation
SU1011126A1 (ru) * 1981-07-14 1983-04-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Средство дл лечени сахарного диабета
CH650677A5 (de) * 1981-08-27 1985-08-15 Lilly Co Eli Gegen diabetes mellitus wirksames pharmazeutisches mittel.
FI78616C (fi) * 1982-02-05 1989-09-11 Novo Industri As Foerfarande foer framstaellning av en foer infusionsaendamaol avsedd stabiliserad insulinloesning, som har en foerhoejd zinkhalt.
AU4292585A (en) * 1984-04-30 1985-11-28 Trustees Of Columbia University In The City Of New York, The Topical treatment of diabetes with insulin and penetrant enhancer applied to the skin and covered by a patch

Also Published As

Publication number Publication date
DK162255C (da) 1992-03-16
NO164277B (no) 1990-06-11
IE57998B1 (en) 1993-06-02
PH24118A (en) 1990-03-05
PT80620B (pt) 1987-10-20
CA1258427A (en) 1989-08-15
EP0166971B1 (de) 1990-02-28
AU4342485A (en) 1985-12-12
ES543972A0 (es) 1986-01-16
DK254585D0 (da) 1985-06-06
NO852314L (no) 1985-12-10
IE851431L (en) 1985-12-09
DK254585A (da) 1985-12-10
FI80596B (fi) 1990-03-30
NZ212338A (en) 1989-02-24
HUT37893A (en) 1986-03-28
PT80620A (de) 1985-07-01
ATE50502T1 (de) 1990-03-15
IL75448A0 (en) 1985-10-31
HU200102B (en) 1990-04-28
FI80596C (fi) 1990-07-10
ES8605679A1 (es) 1986-01-16
GR851393B (en) 1985-11-25
NO164277C (no) 1990-09-19
DE3576120D1 (de) 1990-04-05
AU575951B2 (en) 1988-08-11
FI852273L (fi) 1985-12-10
DK162255B (da) 1991-10-07
EP0166971A1 (de) 1986-01-08
IL75448A (en) 1989-07-31

Similar Documents

Publication Publication Date Title
FI852273A0 (fi) Foerfarande foer framstaellning av en mot mekaniska belastningar stabiliserad vattenhaltig insulinberedning och dess anvaendning.
JPS5776340A (en) Liquid sealed-in vibration-proof apparatus
EP0877912A4 (fi)
DE3866619D1 (de) Biogasreaktor.
DE69010781D1 (de) Vorrichtung für die Thoraxdrainage.
AU7472781A (en) Fluid handling device
DE3276872D1 (en) Installation for introducing gas into a bath of liquid metal
ATE9032T1 (de) Verbindungsteil mit dichtungsring.
DE59906300D1 (de) Fluidischer Stossdämpfer
KR880003090A (ko) 지하 격납식 주차실
DE3564858D1 (en) Arrangement with a sealed evacuated hollow body
ES257901U (es) Cabeza tomamuestras para medidor de velocidad de sedimenta- cion de sangre
ES272644U (es) Ventosa
JPS5748614A (en) Direct viewing type magnet liquid level gage
KR880008212A (ko) 주화 선별장치
JPS5576238A (en) Automobile damper
IT8023226V0 (it) Sonda di misura ad immersione.
MY101782A (en) Method for removing a volatile material from a liquid and equipment for the working of this method
JPS6196333U (fi)
SU1012496A1 (ru) Формовочный стол
JPS569667A (en) Oil reservoir for main bearing of water wheel
IT1244222B (it) Sifone per il passaggio di fluidi, da correnti a superficie libera a correnti in pressione
RU93031533A (ru) Устройство для экстрагирования растительного сырья

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT